摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5,6-dichloro-1H-benzo[d]imidazol-2-yl)methanethiol | 6478-85-9

中文名称
——
中文别名
——
英文名称
(5,6-dichloro-1H-benzo[d]imidazol-2-yl)methanethiol
英文别名
(5,6-dichloro-1H-benzoimidazol-2-yl)-methanethiol;5,6-Dichlor-2-mercaptomethyl-benzimidazol;(5,6-dichloro-1H-benzimidazol-2-yl)methanethiol
(5,6-dichloro-1H-benzo[d]imidazol-2-yl)methanethiol化学式
CAS
6478-85-9
化学式
C8H6Cl2N2S
mdl
——
分子量
233.121
InChiKey
SCRCPSNUWXMJNE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    >300 °C
  • 沸点:
    452.5±35.0 °C(Predicted)
  • 密度:
    1.560±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    29.7
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • PQSR INVERSE AGONISTS
    申请人:Helmholtz-Zentrum für Infektionsforschung GmbH
    公开号:EP3818045A1
    公开(公告)日:2021-05-12
  • PqsR INVERSE AGONISTS
    申请人:HELMHOLTZ-ZENTRUM FÜR INFEKTIONSFORSCHUNG GMBH
    公开号:US20210353606A1
    公开(公告)日:2021-11-18
    The present invention relates to a compound according to general formula (I), which acts as an inhibitor of PqsR (the currently only known receptor for the Pseudomonas Quinolone Signal (PQS)); to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containing at least one compound of the invention and at least one further active pharmaceutical ingredient; and to uses of said compound(s), including the use as a medicament, e.g. the use in the treatment or prophylaxis of a bacterial infection, especially a Pseudomonas aeruginosa or Burkholderia infection.
  • [EN] PqsR INVERSE AGONISTS<br/>[FR] AGONISTES INVERSES DE PQSR
    申请人:HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH
    公开号:WO2020007938A1
    公开(公告)日:2020-01-09
    The present invention relates to a compound according to general formula (I), which acts as an inhibitor of PqsR (the currently only known receptor for the Pseudomonas Quinolone Signal (PQS)); to a pharmaceutical composition containing one or more of the compound(s) of the invention; to a combination preparation containing at least one compound of the invention and at least one further active pharmaceutical ingredient; and to uses of said compound(s), including the use as a medicament, e.g. the use in the treatment or prophylaxis of a bacterial infection, especially a Pseudomonas aeruginosa or Burkholderia infection.
  • WO2020007938A5
    申请人:——
    公开号:WO2020007938A5
    公开(公告)日:2022-07-04
查看更多